State of Wisconsin Investment Board lowered its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 65.4% during the first quarter, Holdings Channel reports. The institutional investor owned 10,383 shares of the company’s stock after selling 19,668 shares during the period. State of Wisconsin Investment Board’s holdings in Nu Skin Enterprises were worth $577,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Creative Planning increased its stake in shares of Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock valued at $100,000 after buying an additional 500 shares in the last quarter. Independent Portfolio Consultants Inc. increased its stake in shares of Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock valued at $132,000 after buying an additional 40 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock valued at $139,000 after buying an additional 468 shares in the last quarter. O Shaughnessy Asset Management LLC increased its stake in shares of Nu Skin Enterprises by 87.5% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 3,811 shares of the company’s stock valued at $182,000 after buying an additional 1,779 shares in the last quarter. Finally, LS Investment Advisors LLC increased its stake in shares of Nu Skin Enterprises by 1,022.1% in the first quarter. LS Investment Advisors LLC now owns 3,658 shares of the company’s stock valued at $203,000 after buying an additional 3,332 shares in the last quarter. 86.65% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises, Inc. (NYSE:NUS) opened at 58.48 on Friday. The company has a market cap of $3.09 billion, a P/E ratio of 19.41 and a beta of 1.36. Nu Skin Enterprises, Inc. has a 52-week low of $42.97 and a 52-week high of $66.04. The company has a 50-day moving average of $56.68 and a 200-day moving average of $52.99.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Wednesday, May 3rd. The company reported $0.51 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.01. The business had revenue of $499.10 million during the quarter, compared to the consensus estimate of $493.65 million. Nu Skin Enterprises had a return on equity of 23.45% and a net margin of 7.48%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 EPS. On average, equities research analysts expect that Nu Skin Enterprises, Inc. will post $3.12 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 14th. Shareholders of record on Friday, May 26th were paid a dividend of $0.36 per share. The ex-dividend date was Wednesday, May 24th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.46%. Nu Skin Enterprises’s dividend payout ratio is currently 48.48%.

ILLEGAL ACTIVITY NOTICE: “State of Wisconsin Investment Board Lowers Stake in Nu Skin Enterprises, Inc. (NUS)” was posted by Financial Market News and is owned by of Financial Market News. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.financial-market-news.com/2017/06/17/state-of-wisconsin-investment-board-lowers-stake-in-nu-skin-enterprises-inc-nus.html.

Several equities research analysts have recently issued reports on NUS shares. Pivotal Research reissued a “buy” rating and set a $65.00 price objective on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Deutsche Bank AG reissued a “buy” rating and set a $63.00 price objective on shares of Nu Skin Enterprises in a research report on Sunday, February 19th. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $63.00 price objective for the company in a research report on Wednesday, April 26th. Finally, Jefferies Group LLC set a $52.00 price objective on shares of Nu Skin Enterprises and gave the stock a “hold” rating in a research report on Friday, February 17th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the stock. Nu Skin Enterprises has an average rating of “Hold” and a consensus target price of $59.00.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the business’s stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $58.32, for a total transaction of $466,560.00. Following the completion of the sale, the general counsel now directly owns 53,730 shares in the company, valued at approximately $3,133,533.60. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Over the last 90 days, insiders have sold 24,000 shares of company stock valued at $1,360,080. Corporate insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.